Indianapolis-based Hopebridge Autism Therapy Centers has named Dr. Adam Hahs its chief science officer. Additionally, the autism services provider has appointed Jana Sarno to the position of chief clinical officer and Kim Strunk as head of clinical strategy.
“Strunk, Hahs and Sarno each bring a unique, highly experienced skillset to our team,” said Hopebridge Chief Executive Officer Dennis May. “I am confident that our investments in clinical excellence and a strong clinical leadership team will not only elevate the quality of care for Hopebridge, but will create advancements for the entire industry as a whole.”
Hopebridge says Hahs will be responsible for driving the company’s research initiatives. He was previously vice president of clinical services at Hopebridge, where he led the International Consortium for Health Outcomes Measurement. Before joining Hopebridge, Hahs was director of the MSABA Program at Arizona State University and was president of the Arizona Association for Behavior Analysis.
“Our organization prides itself on training, developing and collaborating with the brightest minds in behavioral health,” said Hahs. “We’re eager to continue making advancements in research and clinical outcomes through our talented and diverse teams in all areas of early intervention and development, which means heavily investing in the adoption of evidence-based practices that will improve autism care, delivery and outcomes for the families we dedicate our mission to.”
Hopebridge says Sarno will oversee all aspects of clinical training, service-delivery, and strategic planning. Previously, she served as CCO of AIM Clinics, a subsidiary of Hopebridge.
Last month, Hopebridge announced plans to hire more than 4,000 employees to meet demand for ABA therapy.